Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • China launches...

    China launches nationwide action after faulty rabies vaccine

    Written by Ruby Khatun Khatun Published On 2018-08-12T09:30:21+05:30  |  Updated On 12 Aug 2018 9:30 AM IST
    China launches nationwide action after faulty rabies vaccine




    With the recent faulty rabies vaccine scandal creating panic, China has launched a nationwide campaign to provide medical consultation and free inoculation of rabies vaccines.

    Rabies vaccines made by the Changchun Changsheng Life Sciences Company, the second largest in China, were found to have violated national standards including usage of expired fluids and falsified production dates. The vaccines were also widely exported, including to India.

    The Drug Controller General of India early this month ordered an immediate withdrawal of rabies vaccines from the market and also banned their imports from a Chinese manufacturer that allegedly fabricated records.

    Health institutions and disease control centres across China are providing consultation services for people who received rabies vaccines made by the company, state-run Global Times reported today.

    China has designated 36,482 hospitals and health institutions for consultation, the report said.

    No deaths from rabies have been reported among the patients who received the faulty vaccines, it said.

    Investigators found Changchun Changsheng had violated rules on production management and national drug standards for the vaccines since April 2014, including the use of expired fluids and false production dates, the report said.

    China's National Health Commission and the State Drug Administration issued an inoculation plan for people who have received rabies vaccines from the company. Those who are currently being treated and have not completed the required dosage can switch to vaccines from other companies at no charge.

    Those who have completed the vaccination regime can also be re-inoculated without charge if they wish. For those who received the faulty vaccines less than a year ago, vaccination institutions will provide tracking, observation and advisory services, it said.

    The daily quoted a resident surnamed Zhang from Qingdao in East China's Shandong province as saying that she panicked as she received the company's rabies vaccine last autumn and her mother was injected this June at Qingdao's Shibeiqu People's Hospital.



    BannedChangchun Changsheng Life ScienceschinaDrug Controller General of Indiafaultylaunchesmedical consultationsnationwide actionrabies vaccinescandal
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok